Page last updated: 2024-09-04

sclareol and Adenocarcinoma of Lung

sclareol has been researched along with Adenocarcinoma of Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, SY; Huang, HY; Pan, CH; Tsao, SP; Wang, JY; Wei-Chen Chiu, P; Wu, CH	1

Other Studies

1 other study(ies) available for sclareol and Adenocarcinoma of Lung

Article	Year
Sclareol ameliorated ERCC1-mediated cisplatin resistance in A549 human lung adenocarcinoma cells and a murine xenograft tumor model by suppressing AKT-GSK3β-AP1/Snail and JNK-AP1 pathways. Chemico-biological interactions, 2020, Dec-01, Volume: 332 Topics: A549 Cells; Adenocarcinoma of Lung; Animals; Cell Movement; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Drug Synergism; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Models, Biological; Proto-Oncogene Proteins c-akt; Replication Protein C; Snail Family Transcription Factors; Transcription Factor AP-1; Xenograft Model Antitumor Assays	2020

Article

Year

Sclareol ameliorated ERCC1-mediated cisplatin resistance in A549 human lung adenocarcinoma cells and a murine xenograft tumor model by suppressing AKT-GSK3β-AP1/Snail and JNK-AP1 pathways.

Chemico-biological interactions, 2020, Dec-01, Volume: 332

Topics: A549 Cells; Adenocarcinoma of Lung; Animals; Cell Movement; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Drug Synergism; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Models, Biological; Proto-Oncogene Proteins c-akt; Replication Protein C; Snail Family Transcription Factors; Transcription Factor AP-1; Xenograft Model Antitumor Assays

2020